3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Prostatic Neoplasms
7
Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
2
Refractory or Relapsed Solid Tumors
1
Prostatic Neoplasms, Castration-Resistant
1
Non-metastatic Castration-resistant Prostate Cancer
1
Metastatic Castration-resistant Prostate Neoplasms
1
Metastatic Castration-resistant Prostate Cancer
1
Bulbo-Spinal Atrophy, X-Linked
1
Biochemically Recurrent Prostate Cancer
1
Adenocarcinoma
1
Interventions
Cyclophosphamide
5
fludarabine phosphate
4
fludarabine
4
Whole-Body Irradiation
4
Busulfan
4
Injections
3
Cytarabine
3
Azacitidine
3
venetoclax
2
Tacrolimus
2
Stem Cell Transplantation
2
Peripheral Blood Stem Cell Transplantation
2
Mycophenolic Acid
2
Melphalan
2
Lenalidomide
2
Granulocyte Colony-Stimulating Factor
2
Filgrastim
2
Cyclosporine
2
CPX-351
2
Biopsy
2
treosulfan
1
olutasidenib
1
itacitinib
1
eltrombopag
1
decitabine and cedazuridine drug combination
1
canakinumab
1
aldesleukin
1
X-Rays
1
Vorinostat
1
Thiotepa
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leukemia, Myelomonocytic, Chronic
×
darolutamide
×
30 days
×
Clear all
No trials found.